All In MedTech

Device Trial Radar · NCT04658095

Study of OMNI Surgical System and iStent for Eyes With OAG (Trident)

A Prospective, Randomized, Multicenter Study To Compare The Safety And Effectiveness Of The OMNI® Surgical System And The iStent Inject In Pseudophakic Eyes With Open Angle Glaucoma. The TRIDENT European Trial

Last checked: Nov 19, 2026Latest source record: Oct 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

10

Actual

Start

Jan 11, 2022

Primary completion

Nov 18, 2022

Study completion Nov 18, 2022

Sponsor

Lead sponsor
Sight Sciences, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Dec 8, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

First, to compare safety and effectiveness outcomes for canaloplasty and trabeculotomy using the OMNI Surgical System to implantation of the iStent inject in lowering intraocular pressure (IOP) in pseudophakic eyes with open angle glaucoma (OAG), and second, to compare safety and effectiveness outcomes for canaloplasty alone (using the OMNI Surgical System)to implantation of the iStent Inject in lowering IOP in pseudophakic eyes with OAG.

Conditions

  • Glaucoma, Open-Angle

Interventions

  • Canaloplasty and trabeculotomy with the OMNI system.Device

    Ab-interno canaloplasty (360 degrees) and up to 360 degrees trabeculotomy

  • iStent injectDevice

    Ab-interno implantation of iStent inject (2 microstents)

  • CanaloplastyDevice

    Ab-interno canaloplasty (360 degrees) using the OMNI

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change in Unmedicated DIOP From Baseline at the 12-month Postoperative ExaminationTime frame: 12 months

Locations

5 sites in 3 countries. Site status is shown where the registry gives one.

  • BurgerHospital

    Frankfurt, Germany

  • Institut Catala de Retina (ICR)

    Barcelona, Spain

  • Universidad Complutense de Madrid

    Valencia, Spain

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.